PDMC Saves Lives Post-discharge malaria chemoprevention in children with severe anaemia in Benin, Kenya, Malawi and Uganda: Formative and implementation research for policy decision making and implementation
- Coordinator
- Institut De Recherche Pour Le Developpement, France
- Runs
- 1 July 2023 to 31 July 2027
- Status
- Running
- EU funding
- €4.5m
- Total cost
- €4.5m
- Partners
- 8 organisations in 6 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101103078
What the project is doing
In the project's own words, from its summary on CORDIS.
Background: Young children in sub-Saharan Africa are at high risk of severe anaemia, associated with high mortality. Children who have recently recovered from severe anaemia in malaria-endemic areas remain at high risk of mortality for about 3-6 months after hospital discharge. Three months of post-discharge malaria chemoprevention (PDMC) has recently been shown to reduce hospital readmissions by 53% and post-discharge deaths by 77%.
WHO now recommends PDMC in all highly malaria-endemic areas of Africa. However, the optimal strategies for how to deliver PDMC are not yet clear. Objective: To undertake implementation research and translate results into national policy guidelines to promote PDMC uptake into clinical practice so that vulnerable children have access to life-saving medicines. Study design: i) Formative research in two countries in the process of adopting PDMC (Malawi and Uganda) and two, not yet (Kenya and Benin), to identify key research questions for PDMC implementation. ii) Two implementation trials (Benin and Kenya, N=1,824) in recently discharged children following recovery from severe anaemia, co-designed with national stakeholders, will evaluate at least two PDMC delivery strategies involving community-health workers and automated SMS reminders.
The primary outcome will be adherence. Secondary outcomes include clinical and cost-effectiveness, and acceptability and feasibility. Interdisciplinary studies: Acceptability and feasibility; Cost-effectiveness; Policy analysis. Timeline: 49 months: 9m preparation/formative research, 7m trial preparations/co-design, 18m trial implementation, 6m analysis + 9m dissemination/ exploitation and PhD completionImpact: The project is designed to provide evidence to support PDMC implementation.
Partners: Institut De Recherche Pour Le Developpement, France (coordinating partner); LSTM, UK ; EPICENTRE, France; Institut de Recherche Clinique du Benin; Training and Research Unit of Excellence, Malawi; Makerere Uni, Uganda; Kenya Medical Research Institute, Kenya
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Institut De Recherche Pour Le Developpement | Marseille | France | Coordinator |
| Institut De Recherche Clinique Du Benin (ircb) | Cotonou | BJ | Participant |
| Epicentre | Paris | France | Associatedpartner |
| Kenya Medical Research Institute | Nairobi | Kenya | Participant |
| Liverpool School of Tropical Medicine (kenya) Limited | Nairobi | Kenya | Third party |
| Training & Research Unit of Excellence Limited | Blantyre | MW | Participant |
| Makerere University | Kampala | UG | Participant |
| Liverpool School of Tropical Medicine | Liverpool 3 | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI